Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Laos Healthcare Review.
Press releases published on August 18, 2025
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
GlobeNewswire
·
August 18, 2025
LAKEWOOD, Colo., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal …
BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
GlobeNewswire
·
August 18, 2025
DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the Annual Southwest Tech Transfer Showcase, set for Wednesday, September 17th, at the 2025 iC³® Life Science …
WePrevent Launches Florida’s First Comprehensive Prevention Health Platform Amid $100B Chronic Disease Crisis
GlobeNewswire
·
August 18, 2025
Miami, Florida , Aug. 18, 2025 (GLOBE NEWSWIRE) -- WePrevent, a Florida-based health innovation company, today announced the launch of WePrevent.org, the state’s first comprehensive online platform connecting residents with full-spectrum preventive care …
PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight
GlobeNewswire
·
August 18, 2025
New York, USA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight PD-1 inhibitors are projected to dominate future drug sales. Immuno- …
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
GlobeNewswire
·
August 18, 2025
CHICAGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today its financial results for the second quarter and six-month period …
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
GlobeNewswire
·
August 18, 2025
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and …
ACMA Announces Newly Elected National Board Members
GlobeNewswire
·
August 18, 2025
Little Rock, AR, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The American Case Management Association (ACMA) is pleased to announce the results of the 2025 National Board of Directors elections. The following distinguished professionals have been elected to serve on …
Whitsons and The Abbey Group Bring Local Flavor to New England Schools
GlobeNewswire
·
August 18, 2025
Pittsfield, VT, Aug. 18, 2025 (GLOBE NEWSWIRE) -- From Vermont’s rolling dairy farms to Massachusetts’ coastal produce markets, a new partnership is reshaping how students across New England experience school meals. Whitsons Culinary Group® and The Abbey …
Attelia Dental Clinic Wins Prestigious Quality Choice Prize 2025 in Stockholm
GlobeNewswire
·
August 18, 2025
Photo: Founder and Chief Dentist Dr. Mehmet İşlek of Attelia Dental Clinic receiving the Quality Choice Prize 2025 award. ANTALYA, Turkey, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Attelia Oral …
Affidea partners with Skin Analytics to improve access to skin cancer assessment across Europe using AI technology
GlobeNewswire
·
August 18, 2025
THE HAGUE, The Netherlands, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Affidea, a leading pan-European provider of community-based polyclinics, advanced diagnostics, and multi-specialist care, including oncology, has entered a strategic partnership with Skin …
Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 18, 2025
Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- North America leads market expansion as companies advance next-generation ophthalmic therapies to address rising prevalence of vision-threatening diseases The global ophthalmology drugs market, valued at …
Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market
GlobeNewswire
·
August 18, 2025
VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (“Hapbee” or the “Company”) (TSXV: HAPB | OTCQB: HAPBF | FWB: HA1) today announced that Smile Group, a prominent Asia‑based venture builder and growth partner, has made …
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
GlobeNewswire
·
August 18, 2025
The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE). The first WRAP North America patient was enrolled at Bluff City …
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
GlobeNewswire
·
August 18, 2025
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an oral gamma secretase …
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
GlobeNewswire
·
August 18, 2025
Live video webcast on Thursday, August 21st at 1:00 PM ET Register here THE WOODLANDS, TX, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision …
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
GlobeNewswire
·
August 18, 2025
STAMFORD, Conn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commission (EC) granted marketing authorization for OGSIVEO® (nirogacestat), an …
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
GlobeNewswire
·
August 18, 2025
PRESS RELEASE - 08/18/2025, 09:00 AM EDT Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development Itasca (IL), United States, August 18th, 2025 – Biocartis Group of Companies (“Biocartis”), an innovative molecular …
Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support
GlobeNewswire
·
August 18, 2025
MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce the launch of SmartSupport™, a comprehensive, on-demand virtual support platform designed to enhance the procedural experience for clinicians using the EnVisio® In-Body …
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
GlobeNewswire
·
August 18, 2025
First-in-human trial of Capricor’s StealthX™ vaccine initiated under HHS’s Project NextGen Trial conducted and funded by the National Institute of Allergy and Infectious Diseases (NIAID) SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics ( …
Positron Emission Tomography Market to Capture a CAGR of 6.60% While Touching Approximately USD 4.44 Billion by 2034 – Report by Zion Market Research
GlobeNewswire
·
August 18, 2025
NEW YORK, USA, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Positron Emission Tomography Market By Product Type (Partial ring PET scanner, Full ring PET scanner), By Detector Type (Lutetium …